Profile data is unavailable for this security.
About the company
BioRegenx, Inc., formerly Findit, Inc., operates as a holding company. The Company specializes in acquiring intellectual property (IP) and companies engaged in regenerative biotherapeutics and anti-aging research. Its primary focus involves acquiring and developing non-invasive medical and wellness devices capable of efficiently recording, storing, and analyzing datasets. The Company’s patented technologies and solutions include GlycoCheck, a high-definition video imaging that analyzes five parameters of microvascular health non-invasively with an under the tongue test using patented technology; Endocalyx Pro, an all-natural, plant-based patented nutraceutical shown to restore, regenerate, and protect microvascular health. Clinically tested in multiple double-blind placebo studies, and DocSun, an artificial intelligence using three advanced facial recognition technologies that analyzes 21 vital signs and health indicators without physical contact.
- Revenue in USD (TTM)1.29m
- Net income in USD-4.28m
- Incorporated1998
- Employees10.00
- LocationBioRegenx Inc5051 Peachtree Corners CircleNumber 200, Suite 400NORCROSS 30092United StatesUSA
- Phone+1 (404) 443-3224
- Fax+1 (702) 866-2689
- Websitehttps://www.findit.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sigyn Therapeutics Inc | 0.00 | -3.70m | 8.67m | 5.00 | -- | -- | -- | -- | -3.08 | -3.08 | 0.00 | -2.91 | 0.00 | -- | -- | 0.00 | -1,085.72 | -493.15 | -- | -- | -- | -- | -- | -10,223.96 | 0.0247 | -2.09 | -- | -- | -- | -- | -41.51 | -- | -- | -- |
| Applied DNA Sciences Inc | 3.40m | -7.52m | 9.20m | 53.00 | -- | 0.1514 | -- | 2.71 | -11.86 | -11.86 | 2.18 | 1.20 | 0.2092 | 6.83 | 5.68 | 64,114.15 | -45.51 | -88.57 | -55.20 | -121.91 | 25.04 | 44.35 | -217.48 | -113.26 | 3.76 | -- | 0.00 | -- | -26.43 | 27.92 | -18.73 | -- | 33.80 | -- |
| Precipio Inc | 16.72m | -3.83m | 9.41m | 51.00 | -- | 0.7703 | -- | 0.563 | -2.68 | -2.68 | 11.73 | 8.24 | 0.9089 | 17.12 | 16.80 | 327,843.10 | -20.82 | -44.98 | -27.94 | -58.68 | 39.08 | 28.80 | -22.90 | -118.07 | 0.590 | -192.59 | 0.0517 | -- | 61.46 | 39.62 | 52.04 | -- | 5.37 | -- |
| T2 Biosystems Inc | 7.16m | -48.26m | 9.58m | 113.00 | -- | -- | -- | 1.34 | -10.70 | -10.70 | 1.09 | -0.3391 | 0.2435 | 2.82 | 5.41 | 63,398.23 | -164.01 | -106.01 | -- | -253.03 | -86.96 | -12.60 | -673.67 | -317.93 | 0.359 | -12.44 | 2.00 | -- | -67.75 | -7.29 | 19.66 | -- | -20.19 | -- |
| REMSleep Holdings Inc | 144.88k | -1.81m | 9.81m | 6.00 | -- | 17.05 | -- | 67.70 | -0.0012 | -0.0012 | 0.0001 | 0.0004 | 0.08 | 1.69 | 4.75 | -- | -99.82 | -152.40 | -122.32 | -317.98 | -491.08 | -- | -1,246.94 | -2,317.52 | 1.47 | -43.58 | 0.1207 | -- | -36.48 | -- | 12.13 | -- | 28.26 | -- |
| PetVivo Holdings Inc | 975.28k | -10.11m | 9.86m | 20.00 | -- | 11.83 | -- | 10.11 | -0.6705 | -0.6705 | 0.062 | 0.0417 | 0.3257 | 0.405 | 16.37 | 48,764.00 | -337.63 | -230.77 | -589.09 | -467.99 | 83.60 | 66.21 | -1,036.50 | -1,501.44 | 0.455 | -1,075.05 | 0.0221 | -- | 5.62 | -- | -25.67 | -- | 23.91 | -- |
| QT Imaging Holdings Inc | 0.00 | -4.02m | 10.19m | -- | -- | 0.4686 | -- | -- | -0.3999 | -0.3999 | 0.00 | 1.01 | 0.00 | -- | -- | -- | -12.32 | -- | -16.60 | -- | -- | -- | -- | -- | -- | -- | 0.3042 | -- | -- | -- | -45.07 | -- | -- | -- |
| PAVmed Inc | 3.83m | -67.35m | 10.61m | 107.00 | -- | -- | -- | 2.77 | -8.17 | -8.17 | 0.4595 | -7.74 | 0.0823 | -- | 29.45 | 35,785.05 | -155.93 | -154.56 | -- | -1,152.82 | -77.59 | -- | -1,895.64 | -8,764.89 | 0.5529 | -8.16 | 1.74 | -- | 550.40 | -- | 25.76 | -- | 55.51 | -- |
| SeaStar Medical Holding Corp | 0.00 | -33.23m | 10.99m | 12.00 | -- | -- | -- | -- | -21.41 | -21.41 | 0.00 | -2.14 | 0.00 | -- | -- | 0.00 | -1,145.80 | -- | -- | -- | -- | -- | -- | -- | -- | -9.51 | -- | -- | -- | -- | -115.19 | -- | -- | -- |
| Golden Valley Development Inc | 0.00 | -92.53k | 11.63m | 0.00 | -- | -- | -- | -- | -11.17 | -11.17 | 0.00 | -0.0211 | 0.00 | -- | -- | -- | -7,710.83 | -- | -- | -- | -- | -- | -- | -3,073.27 | -- | -3.96 | -- | -- | -- | -- | 45.48 | -- | -- | -- |
| Guided Therapeutics Inc | 38.00k | -2.39m | 11.68m | 4.00 | -- | -- | -- | 307.30 | -0.0444 | -0.0444 | 0.0007 | -0.0829 | 0.0211 | 0.0365 | 8.44 | 9,500.00 | -120.81 | -136.13 | -- | -- | 42.11 | 29.39 | -5,721.05 | -3,666.67 | 0.0679 | -7.58 | -- | -- | 653.85 | 11.45 | 24.40 | -- | -- | -- |
| Autonomix Medical Inc | -100.00bn | -100.00bn | 11.82m | 5.00 | -- | 1.87 | -- | -- | -- | -- | -- | 5.50 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.1647 | -- | -- | -- | -674.99 | -- | -- | -- |
| BioRegenx Inc | 1.29m | -4.28m | 11.96m | 10.00 | -- | 0.8408 | -- | 9.25 | -0.0053 | -0.0053 | 0.0023 | 0.0149 | 0.1438 | -- | -- | 129,234.00 | -47.59 | -- | -58.94 | -- | 66.76 | -- | -331.00 | -- | 0.0533 | -28.81 | 0.1284 | -- | -47.25 | -- | -629.37 | -- | -- | -- |
| STRATA Skin Sciences Inc | 32.73m | -8.31m | 13.96m | 99.00 | -- | 1.24 | -- | 0.4265 | -2.37 | -2.37 | 9.35 | 2.71 | 0.6906 | 3.47 | 7.81 | 330,606.10 | -17.54 | -11.48 | -24.26 | -16.55 | 54.30 | 61.28 | -25.40 | -17.70 | 0.9176 | -2.69 | 0.6141 | -- | -7.75 | 2.24 | -95.17 | -- | 23.29 | -- |
| Meihua International Medical Tech Co Ltd | 94.25m | 9.28m | 14.60m | 617.00 | 1.50 | 0.0903 | 1.50 | 0.1549 | 0.3442 | 0.3442 | 3.45 | 5.73 | 0.5516 | 46.02 | 1.16 | 152,759.40 | 5.42 | 12.26 | 6.43 | 15.05 | 33.12 | 38.14 | 9.84 | 15.47 | 4.74 | -- | 0.0729 | 0.00 | -6.05 | 5.10 | 86.22 | -5.56 | -9.16 | -- |
| Vivos Therapeutics Inc | 14.02m | -12.05m | 14.87m | 114.00 | -- | 1.67 | -- | 1.06 | -6.98 | -6.98 | 6.88 | 1.87 | 0.9477 | -- | 38.84 | 123,000.00 | -81.41 | -89.72 | -166.05 | -149.70 | 60.08 | 70.20 | -85.90 | -113.15 | -- | -- | 0.00 | -- | -13.87 | 29.48 | 43.04 | -- | -8.48 | -- |
Data as of Nov 13 2024. Currency figures normalised to BioRegenx Inc's reporting currency: US Dollar USD
